2015
DOI: 10.1590/s0102-865020150060000004
|View full text |Cite
|
Sign up to set email alerts
|

Selenium protects cerebral cells by cisplatin induced neurotoxicity

Abstract: PURPOSE:To evaluate the central nervous system toxicity of cisplatin and neuroprotective effect of selenium. METHODS:Twenty-one male Wistar albino rats were divided into three groups: control (C), cisplatin (CS), cisplatin and selenium (CSE, n=7 in each group). Cisplatin (12 mg/kg/day, i.p.) was administered to CS and CSE groups for three days. Furthermore, CSE group received 3mg/kg/day (twice-a-day as 1.5 mg/kg) selenium via oral gavage five days before cisplatin injection and continued for 11 consecutive day… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 31 publications
1
12
0
Order By: Relevance
“…CP binds to the nuclear and mitochondrial DNA of the neurons, which may trigger the activation of RhoA GTPase enzyme and induction of the inflammatory pathways 38,39 . Nuclear DNA damage leads to p53 activation and triggers apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…CP binds to the nuclear and mitochondrial DNA of the neurons, which may trigger the activation of RhoA GTPase enzyme and induction of the inflammatory pathways 38,39 . Nuclear DNA damage leads to p53 activation and triggers apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…With prolonged treatment, they gradually lead to disturbance of proprioception, which may result in ataxic gait [ 23 ]. The clinical manifestations of encephalopathy accompanying platinum-based therapy usually appear with an increase in cumulative dose [ 24 ]. Sensory manifestations of platinum compounds-induced neuropathy are often accompanied by ototoxicity [ 25 ].…”
Section: Side Effects Of Platinum-based Compounds In Clinical Pracmentioning
confidence: 99%
“…Selenium has been demonstrated to reduce ROS production [15, 16], protect cells against glutamate toxicity [17], oxidative stress [18] and inflammatory cytokines [19, 20]. Animal experiments have showed that selenium supplementation reduces ROS production, ameliorates cisplatin induced neurotoxicity and ischemia-induced brain damage [21, 22]. However, the mechanisms by which selenium exerts its protective effect against glutamate insult in neuronal cells remains ambiguous.…”
Section: Introductionmentioning
confidence: 99%